Jiabiyou (688089.SH) announced its 2023 annual results, with net profit of 91.3742 million yuan, an increase of 41.95% over the previous year

Jia Biyou (688089.SH) released its 2023 annual report. The company's revenue was 444 million yuan, compared with...

Zhitong FinanceApr 26 06:07 ET

Shanxi Securities: Currently, the underlying technology of synthetic biology still has a lot of room for improvement, and product companies are easier to grow

The Zhitong Finance App learned that Shanxi Securities released a research report saying that currently there is still a lot of room for improvement in the underlying synthetic biology technology, the industry is still in the early stages of the life cycle, and product companies are more likely to grow. From a short-term perspective, product selection ability will have a critical impact on the short-term financial performance of product companies. Excellent products should have the two characteristics of “mature downstream application” and “cost leadership” to solve actual commercial needs: mature downstream applications: 1) the potential market is broad; 2) the demand is deterministic, and the market cost education is low. Cost leadership: The probability of technology implementation is high, and it has a cost advantage over existing alternative products. longterm

Zhitong FinanceApr 3 02:39 ET

Jia Biyou (688089.SH): The trend of replacing fish oil with algae oil has gradually emerged in recent years

Gelonghui, March 19 | Jia Biyou (688089.SH) said on the investor interactive platform that the company currently produces algae oil DHA independently. After the fund-raising project is put into operation, the DHA oil production capacity can be increased from 150 tons to 600 tons. The powder production capacity is shared between ARA and DHA, and the total powder production capacity has also increased from 1,200 tons to 2,700 tons. Fish oil DHA and algae oil DHA each have obvious advantages in different application scenarios. Because seaweed oil DHA is produced in sealed fermenters through biological fermentation technology, the production process is clean, controllable and traceable, and is more environmentally friendly and safe, plus algae oil DH

Gelonghui FinanceMar 19 05:01 ET

Jia Biyou (688089.SH): Net profit increased 42.17% year on year in 2023

Gelonghui, Feb. 23: Jiabiyou (688089.SH) announced its 2023 annual performance report. In 2023, the company achieved operating income of 445,467,157.19 yuan, an increase of 2.78% over the same period last year; net profit attributable to owners of the parent company was 91,520,557.02 yuan, an increase of 42.17% over the same period last year; net profit attributable to owners of the parent company after deducting non-recurring gains and losses was 68,203,967.19 yuan, an increase of 121.88% over the same period last year. During the reporting period, new national standards for infant formula were implemented, and required

Gelonghui FinanceFeb 23 03:47 ET

Jia Biyou (688089.SH): Net profit of 2023 was 91.56 million yuan, up 42.17% year on year

According to Zhitong Finance App News, Jia Biyou (688089.SH) released the 2023 annual performance report, with total operating revenue of 445 million yuan, up 2.78% year on year; net profit attributable to owners of the parent company was 91.56 million yuan, up 42.17% year on year; net profit attributable to owners of the parent company after deducting non-recurring profit and loss was 68.204 million yuan, up 121.88% year on year; basic earnings per share were 0.54 yuan. During the reporting period, new national standards for infant formula were implemented, and increased demand led to an increase in revenue for the company's ARA and DHA products. 2023

Zhitong FinanceFeb 23 03:44 ET

Jia Biyou (688089.SH): New hMOS series products developed using synthetic biology technology are accelerating industrialization

Gelonghui, Feb. 7 | Jia Biyou (688089.SH) said on the investor interactive platform that Jia Biyou is a company that develops and produces bio-based nutritional chemicals using synthetic biology as the underlying technology and cell factories as preparation methods. Since its establishment, the company has been deeply involved in the field of nutrition and health, gradually built a food safety and supply chain management system that meets international standards, and has become a core ingredient supplier to the global infant formula industry. Based on the three expansion strategies of “expanding to diversified application fields, expanding to diversified products, and expanding to the international market”, the company's main business is based on the rich academic functions of the product

Gelonghui FinanceFeb 7 07:28 ET